Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Omega-3 supplements 'do not reduce CV risk'

Guidelines supporting an increased intake of omega-3 fatty acids to prevent cardiovascular disease in those at high-risk are not supported by trials, say Greek researchers.

Their analysis pooled 20 randomised controlled trials looking at 68,680 patients aged 49 to 70 years taking omega-3 polyunsaturated fatty acids for primary or secondary prevention of cardiovascular disease.

Patients were randomised to either a diet high in omega-3 polyunsaturated fatty acids or supplements, and the effects were compared with controls on an alternative diet or placebo, for at least one year.

They found that the risk of all-cause mortality was reduced by just 4% compared with controls, and this difference was not statistically significant. Risk of cardiac death was reduced by 9%, sudden death by 13% and myocardial infarction by 11% compared with controls. None of these reductions were statistically significant.

Omega-3 supplements increased the risk of stroke by 5% compared with controls, but this increase was statistically non-significant.

The researchers concluded: ‘Our findings do not justify the use of omega-3 as a structured intervention in everyday clinical practice or guidelines supporting dietary omega-3 PUFA administration.'

JAMA 2012, published online 12 September

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say